Brainstorm Cell Therapeutics Inc

Jun 24, 2020

BrainStorm Expands Clinical Pipeline to Evaluate NurOwn® for the Treatment of Alzheimer's Disease

Jun 23, 2020

BrainStorm Cell Therapeutics to Join the Russell 2000® Index and Russell 3000® Index

Jun 11, 2020

BrainStorm to Present at the Raymond James Human Health Innovations Conference

Jun 09, 2020

The ALS Association, I AM ALS Award BrainStorm Cell Therapeutics $500,000 for ALS Biomarker Study

Jun 03, 2020

BrainStorm to Participate in BIO Digital 2020

Jun 02, 2020

BrainStorm Announces that Pivotal Phase 3 Trial Remains on Track for Topline Data in Q4-2020

May 27, 2020

BrainStorm Appoints Pharmaceutical Veteran Stacy R. Lindborg, Ph.D. as Executive Vice President, Head of Global Clinical Research